Medpace Holdings, Inc. (MEDP)

Market Cap	16.24B
Revenue (ttm)	2.36B
Net Income (ttm)	432.92M
Shares Out	28.17M
EPS (ttm)	14.32
PE Ratio	40.26
Forward PE	35.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	245,168
Open	584.59
Previous Close	583.70
Day's Range	571.30 - 592.15
52-Week Range	250.05 - 626.26
Beta	1.43
Analysts	Hold
Price Target	465.18 (-19.31%)
Earnings Date	Oct 22, 2025

About MEDP

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigi...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 11, 2016
• Employees: 5,900
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDP
• Website: https://www.medpace.com

Financial Performance

In 2024, Medpace Holdings's revenue was $2.11 billion, an increase of 11.84% compared to the previous year's $1.89 billion. Earnings were $404.34 million, an increase of 43.07%.

Analyst Summary

According to 12 analysts, the average rating for MEDP stock is "Hold." The 12-month stock price target is $465.18, which is a decrease of -19.31% from the latest price.

Price Target

$465.18

(-19.31% downside)

Analyst Consensus: Hold